 Q BioMed Inc. OTCQB:QBIO said it has received a European Certificate of Grant for GDF15, a diagnostic marker for determining the severity of glaucoma using the expression levels of Growth Differentiation Factor 15 GDF15 licensed from the Washington University in St. Louis, Missouri. 